---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-25-000014"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T03:22:09.943406+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Prestige Q4 revenue $296.5M, adj EPS $1.32; FY25 adj EPS $4.52; FY26 outlook $4.70-4.82

## Summary
- Q4 revenue $296.5M (+7.0% YoY, organic +7.9%); diluted EPS $1.00 GAAP, adjusted $1.32 (vs $1.02 prior year).
- FY2025 revenue $1,137.8M (+1.1%); diluted EPS $4.29 GAAP, adjusted $4.52 (+7.4% vs $4.21 prior year).
- Free cash flow $243.3M in FY2025 (+1.6% YoY); leverage ratio reduced to 2.4x at year-end.
- Initial FY2026 outlook: organic revenue growth ~1-2%, diluted EPS $4.70-4.82, free cash flow $245M or more.
- Management guides mid-to-high single-digit EPS growth despite ~$15M tariff headwind.

## SEC filing metadata
- accession: 0001295947-25-000014
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000014/0001295947-25-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000014/pbh-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-25-000014
- JSON: https://secwatch.observer/filing/0001295947-25-000014.json
- Plain text: https://secwatch.observer/filing/0001295947-25-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.